Is AEGIS™ The Synbiotic Your Gut Needs? →
Shop Ingredients Contact us

The Science

Real health starts in the gut

  • Your gut is not a passive tube that processes food. It is one of the most active regulatory systems in your body, in constant two way communication with your immune system, your nervous system, your skin and your metabolism.
  • But here is the part almost no one tells you. A probiotic can only do any of this if it arrives alive, in the right place, in numbers that matter. Most never do.
  • This page is about how we think about that problem, and the choices behind AEGIS. We have gone deeper than most brands are willing to, because you should be able to see exactly what you are taking and why.

Two things have to go right, and usually neither does

Most probiotics fail before they begin. Not because the strains are weak, but because they never survive the trip.

The first obstacle is your stomach. It sits at a pH of roughly 1.5 to 3.5, acidic enough to break down almost everything you swallow. That acidity strips the protective membrane of a bacterial cell and unravels the proteins it needs to function. A live culture dropped into that environment in an ordinary capsule is largely gone within minutes.

The second obstacle comes right after. As the capsule empties into the small intestine, the bacteria meet bile salts, which your body uses to break down fats and which are also hostile to microbial cells. So even the cultures that survive the acid often do not survive what follows.

Both of these happen before the bacteria reach the large intestine, which is the only place they can actually settle in and do their work.

This is the quiet problem with the whole category. The CFU count printed on a label is measured at the moment of manufacture. It is not measured when the culture reaches your gut, and it is certainly not measured after the stomach and the bile have had their say. The gap between the number on the bottle and the number that arrives can be enormous.

So if you have taken probiotics before and felt nothing, this is the most likely reason. The strains were real. The science behind them was real. They simply never arrived.

Built around delivery, not the label

AEGIS is a capsule within a capsule. Two compartments, two release events, one outcome.

The outer capsule releases first. It carries XOS, a prebiotic fibre. XOS is built from chains of xylose linked together in a way your own digestive enzymes cannot cut, which means it passes through the stomach and small intestine untouched and arrives in the colon intact. There it is selectively fermented by the Bifidobacterium and Lactobacillus already living in you. In plain terms, it feeds the gut and prepares the ground, so that what comes next has somewhere to land and something to eat.

The inner capsule releases second. It holds the live strains, shielded through the acid and the bile, and opens in the large intestine. Protected on the way down. Fed on arrival.

Most delivery systems try to do one of these things. AEGIS does both, in sequence. That is why it is the only capsule within a capsule synbiotic available in Australia.

What a healthy gut actually does: short chain fatty acids

This is the part most brands skip, and it is the part that ties everything together.

When fibre like XOS reaches the colon and your bacteria ferment it, they produce short chain fatty acids, mainly acetate, propionate and butyrate. These are not a side effect. They are most of the point.

Butyrate in particular is the primary fuel for the cells that line your colon. Those cells run almost entirely on it. A gut producing plenty of butyrate is a gut whose lining is well fed, which supports the integrity of the barrier between your gut contents and the rest of your body.

Short chain fatty acids do not stay put either. Some are absorbed into your bloodstream and act as signalling molecules elsewhere, which is one of the mechanisms by which the state of your gut reaches the rest of you. This is the bridge between what you swallow and the whole body effects people associate with gut health. No fibre reaching the colon, no fermentation. No fermentation, no short chain fatty acids. It is why a synbiotic, fibre and bacteria together, is built differently from a probiotic alone.

Strains are not interchangeable

It is tempting to treat probiotics as a single ingredient. They are not.

Bacteria are identified at three levels: genus, species and strain. Lactobacillus is a genus. Lactobacillus rhamnosus is a species. Lactobacillus rhamnosus GG is a specific strain. Within a single species there are thousands of genetically distinct strains, and they do not behave the same. They settle in different parts of the gut, interact with the body in different ways, and are backed by different research. Two products can both say Lactobacillus rhamnosus on the label and share almost nothing in common.

This is why we identify every strain down to its strain designation, the same level of detail clinical research is conducted at, rather than hiding behind the words proprietary blend. One of the strains in AEGIS, Lactobacillus rhamnosus GG, is among the most studied probiotic strains in the world. You can look it up. You should be able to.

The 22 strains are organised into four blends, each oriented toward a different aspect of how the gut influences the body: a gastrointestinal blend, a dermatological blend, a systemic immunity blend and a metabolic blend. They were chosen because the published literature pointed to them, not because they were cheap or easy to source.

There is also a point at which a strain becomes biologically meaningful, and below which it largely does not. Research consistently shows this dose response relationship. AEGIS delivers 45 billion live cultures across those 22 strains in a single daily capsule, with each present at a level the evidence supports, rather than one large number chosen to look impressive on a label.

Colonisation, not just transit

Here is a distinction that matters and almost never gets mentioned.

Some strains pass straight through you. They show up, do very little, and leave. These are transient strains. Others can establish themselves and persist, adding to the diversity of your microbiome over time. These have documented colonisation capacity.

A high CFU count tells you how many cells went in. It tells you nothing about how many stayed. We select strains with evidence of colonisation, because a probiotic that does not stick is a probiotic that does not last. This is also why results build over weeks rather than overnight. You are not topping up a tank, you are slowly changing who lives there.

Alive in the bottle, alive in you

Keeping bacteria alive from the lab to your gut is its own discipline.

The strains are grown under tightly controlled fermentation, where temperature, pH, oxygen and nutrients are held within narrow ranges. Drift on any one of them and viability suffers.

They are then freeze dried, a process also called lyophilisation. Water is removed from the cells under low temperature and low pressure, and protective compounds are used to keep the cell structure intact as it dries. What is left is bacteria in a dormant, glass like state. Stable on a shelf, no refrigeration required, with their viability preserved. They stay dormant until they meet the moisture and warmth of your gut, where they rehydrate and reactivate.

This is why how a probiotic is made matters as much as what is in it. A strain with excellent research behind it is worthless if it is dead by the time you swallow it.

The gut talks to the rest of you

A healthy gut is not only about digestion. The microbiome is increasingly understood as a regulator that reaches well beyond the gut wall, and the short chain fatty acids and signalling molecules it produces are a large part of how.

The gut and the brain. Your gut contains around 500 million neurons, a network sometimes called the second brain, connected to your actual brain by the vagus nerve. Gut bacteria are involved in producing the precursors to many of the body's key signalling molecules, including the majority of its serotonin, which is made in the gut rather than the head. How your microbiome is composed is an active area of research into mood, stress and focus.

The gut and the skin. The gut and the skin are both barrier organs. Their job is to decide what gets in and what stays out. Research links the condition of the gut barrier to the condition of the skin, partly through the inflammatory signalling that travels between them. Clear, calm, healthy looking skin is increasingly traced back to what is happening in the microbiome rather than only what is happening on the surface.

The gut and the immune system. The lining of your gut holds the majority of the body's immune cells, in tissue that sits directly against the microbial environment. The microbiome is in constant conversation with it, helping to train how the immune system tells friend from threat and how strongly it responds. A diverse, well populated microbiome supports that conversation. A depleted one does not.

The thread running through all of it is diversity. A varied microbiome is a resilient one, and resilience is what lets the gut keep doing its job of regulating everything else.

Tested to a standard you should not have to question

Every batch of AEGIS is independently tested for purity, for heavy metals and contaminants, and for consistency, so the product you take on day three hundred matches the one you took on day one. The strains are identified, the ingredients are traceable. What you take every day should meet a standard you never have to think about.

The whole idea

None of this is about printing a bigger number on a label. It is about how many living cultures actually reach the one place they can work, arrive fed, stay long enough to matter, and produce the short chain fatty acids that let the gut do everything else it does.

References

  1. Survival: stomach acid, bile, and why most probiotics never arrive
  2. 1. Han S, et al. Probiotic Gastrointestinal Transit and Colonization After Oral Administration: A Long Journey. Frontiers in Cellular and Infection Microbiology. 2021;11:609722.
  3. https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2021.609722/full
  4. Supports: gastric acid, bile salts and digestive enzymes challenge probiotic viability before they reach the gut; surviving cells must then compete to colonise.
  5. 2. Assessing Viability and Stress Tolerance of Probiotics: A Review. Frontiers in Microbiology. 2021;12:818468.
  6. https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2021.818468/full
  7. Supports: the upper gastrointestinal tract exposes probiotics to low pH and bile; survival is strain dependent and depends on the product format; tolerance is often only tested during research, not in the final consumer product.
  8. Delivery: XOS prebiotic and the synbiotic rationale
  9. 3. A review of the capacity of xylooligosaccharides to modulate gut microbiota and promote health. Food & Function. 2025. DOI 10.1039/D5FO00169B.
  10. https://pubs.rsc.org/en/content/articlehtml/2025/fo/d5fo00169b
  11. Supports: XOS is built from xylose units in linkages resistant to human digestion, so it reaches the colon intact, where it is selectively fermented and has a bifidogenic effect that stimulates short chain fatty acid production.
  12. 4. The Potential of Xylooligosaccharides as Prebiotics and Their Sustainable Production. PMC. 2023.
  13. https://pmc.ncbi.nlm.nih.gov/articles/PMC10379617/
  14. Supports: XOS is stable under stomach pH and digestive enzymes and is metabolised mainly by Bifidobacterium and Lactobacillus in the lower intestine.
  15. 5. Swanson KS, et al. The ISAPP consensus statement on the definition and scope of synbiotics. Nature Reviews Gastroenterology & Hepatology. 2020;17:687-701.
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC7581511/
  17. Supports: the formal definition of a synbiotic as live microorganisms plus a substrate selectively used by host microorganisms. Backs the "fibre and bacteria together" framing.
  18. Short chain fatty acids: what a working gut actually produces
  19. 6. Parada Venegas D, et al. Short Chain Fatty Acids (SCFAs) Mediated Gut Epithelial and Immune Regulation. Frontiers in Immunology. 2019;10:277.
  20. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00277/full
  21. Supports: butyrate is the main energy source of colonocytes, strengthens the gut barrier, and has immunomodulatory functions.
  22. 7. Beyond the Gut: Unveiling Butyrate's Global Health Impact Through Gut Health. PMC. 2025.
  23. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12029953/
  24. Supports: butyrate as fuel for colonocytes, its role in gut barrier preservation and tight junction integrity, and its anti-inflammatory activity.
  25. 8. A review of short chain fatty acids in gut and skin: possible implications in skin aging. Journal of Functional Foods. 2025.
  26. https://www.sciencedirect.com/science/article/pii/S1756464625003524
  27. Supports: SCFAs fuel colonocytes and tighten the gut barrier, and after absorption travel via the bloodstream to distant organs including the skin, where they influence skin barrier function. Backs both the SCFA circulation point and the gut and skin connection.
  28. The gut and the brain
  29. 9. Interaction of the Vagus Nerve and Serotonin in the Gut Brain Axis. International Journal of Molecular Sciences. 2025;26(3):1160.
  30. https://www.mdpi.com/1422-0067/26/3/1160
  31. Supports: roughly 90 percent of the body's serotonin is made in the gut, predominantly by enterochromaffin cells; gut derived serotonin signals to the brain via the vagus nerve.
  32. 10. Microbiota gut brain axis and its therapeutic applications. Signal Transduction and Targeted Therapy. 2024.
  33. https://www.nature.com/articles/s41392-024-01743-1
  34. Supports: bidirectional gut to brain communication via the vagus nerve, enteric nervous system and immune system; gut bacteria produce or stimulate neurotransmitters including serotonin, dopamine and GABA.
  35. Label claims versus reality
  36. 11. National Institutes of Health, Office of Dietary Supplements. Probiotics: Health Professional Fact Sheet.
  37. https://ods.od.nih.gov/factsheets/Probiotics-HealthProfessional/
  38. Supports: the central claim. ISAPP advises manufacturers to list CFU through the expiry date and advises consumers to avoid products that list CFU at time of manufacture, because that number does not account for the decline in viable cells over shelf life.
  39. Strains are not interchangeable, and dose matters
  40. 12. Hill C, et al. The ISAPP consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology. 2014;11:506-514. DOI 10.1038/nrgastro.2014.66.
  41. https://doi.org/10.1038/nrgastro.2014.66
  42. Supports: probiotic effects are strain specific, not shared across a whole genus or species; effective use depends on an adequate dose. The cornerstone reference for the strain specificity argument.
  43. 13. Binda S, et al. Criteria to Qualify Microorganisms as Probiotic in Foods and Dietary Supplements. Frontiers in Microbiology. 2020;11:1662.
  44. https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2020.01662/full
  45. Supports: a qualifying probiotic must be sufficiently characterised and present alive at an effective dose throughout shelf life. Backs both the dosing point and the testing point.
  46. The gut and the immune system
  47. 14. Human gut associated lymphoid tissues (GALT): diversity, structure, and function. Mucosal Immunology / ScienceDirect. 2022.
  48. https://www.sciencedirect.com/science/article/pii/S1933021922001799
  49. Supports: GALT is the body's largest collection of immune tissue, sits in direct contact with the gut microbial environment, and helps regulate immune responses.
  50. Keeping strains alive: freeze drying
  51. 15. Freeze Drying for Probiotic Encapsulation: Technological Advances and Food Chemistry Insights. ACS Food Science & Technology. 2026.
  52. https://pubs.acs.org/doi/10.1021/acsfoodscitech.5c01089
  53. Supports: freeze drying preserves cell integrity by removing water under low temperature and pressure, maintaining viability after rehydration.
  54. 16. Optimization of cryoprotectants and storage temperatures for preserving viability of lyophilized bacterial strains. PLOS One. 2025.
  55. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0328216
  56. Supports: the freeze drying and cryoprotectant mechanism (water removal, membrane stabilisation, a glass like protective matrix) and the dormant, shelf stable state. Also notes that a meaningful share of probiotic products fail to meet their label claims by expiry.
  57. Compiled from peer reviewed literature and authoritative public health sources. Verify each source against the claim it supports before publication. These references support general mechanisms of gut physiology and probiotic science, and do not constitute evidence of efficacy for any specific finished product.